Shandong Weigao repurchases 1.95m H shares for HK$11.4m

On September 17, 2025, Shandong Weigao Group Medical Polymer Company Limited repurchased 1,954,800 H shares on the Exchange at a volume-weighted average price of HK$5.8448 per share. Prices for the shares ranged from HK$5.82 to HK$5.9. The aggregate price paid for these shares amounted to HK$11,425,480.

These repurchased shares will be held as treasury shares, increasing the total number of treasury shares from 18,907,200 to 20,862,000. Following the repurchase, the company's number of issued shares (excluding treasury shares) decreased from 4,503,425,124 to 4,501,470,324. This represents a 0.0434% change in the number of issued shares prior to the event. The total number of issued shares remains unchanged at 4,522,332,324.

The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares. To date, 14,213,600 shares have been repurchased on the Exchange under this mandate, representing 3.1477% of the issued shares (excluding treasury shares) as of the resolution date. A moratorium period for new share issues or treasury share sales is in effect until October 17, 2025.